TransTech Pharma is a privately held clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of human therapeutics to fill unmet medical needs.  The Company’s mission is to utilize its innovative drug discovery platform, Translational Technology to rapidly translate the functional modulation of human proteins into safe and effective medicines. TransTech has a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including cardiovascular disorders, central nervous system disorders, type I/II diabetes, obesity, and oncology.   In addition to its internal drug discovery programs, TransTech is also involved in various research collaborations with large pharmaceutical companies.